Open AccessPredictors of the response to nivolumab immunotherapy in the second or subsequent lines for metastatic non‑small cell lung cancers
Author(s) -
Sorin Săftescu,
Șerban Negru,
Simona Ruxandra Volovăț,
D Popovici,
Vlad Chercota,
Simona Stanca,
Horéa Feier,
Daniel Malița,
Radu Dragomir,
Constantin Volovăț
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10037
Subject(s) - nivolumab , medicine , oncology , lung cancer , tolerability , immunotherapy , predictive marker , cancer , melanoma , immunology , cancer research , adverse effect